Search Results
Feb 26, 2026, 19:24 ET Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics
SAN DIEGO, Feb. 27, 2026 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a suite of powerful advancements that will significantly accelerate the next era of genomic
More news about: Illumina
Feb 26, 2026, 16:26 ET Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business
resultsBOSTON, Feb. 26, 2026 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced its results for the fourth quarter and full year ended December 31, 2025. The update, including a webcast slide presentation
More news about: Ginkgo Bioworks
Feb 26, 2026, 14:59 ET Março Lilás: Casos de câncer de colo do útero devem crescer 14% no Brasil(1, 2)
pública6.A recomendação da OMS inclui a vacinação contra o HPV, a realização de exames de rotina (Papanicolau e o teste de DNA-HPV7) e o tratamento adequado de lesões pré-cancerígenas6.Diante desse cenário de saúde pública, a MSD Brasil, em parceria
More news about: MSD Brasil
Feb 26, 2026, 14:50 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO
development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papilloma virus ("HPV"). The Company's DNA medicines are comprised of two components: (i) DNA plasmids, which are small circular DNA molecules that purportedly work like
More news about: Pomerantz LLP
Feb 26, 2026, 12:08 ET Dr. Adrienne O'Connell Introduces SKINformed: A Medical-Grade Skincare Line Rooted in Science, Integrity, and Results
trust. Her concierge approach to aesthetics emphasizes individualized care, education, and natural-looking results. These values are woven into the DNA of SKINformed.Founded in 2025, SKINformed reflects Dr. O'Connell's belief that powerful skincare should feel both intelligent and indulgent; where
More news about: SKINformed Skincare
Feb 26, 2026, 11:16 ET Volta Labs beflügelt die AGBT 2026 mit bedeutenden Produkteinführungen und branchenprägenden Partnerschaften
versuchen, den AXELIOS 1 SBX-D-Vorbereitungs-Workflow in die Callisto-Plattform zu integrieren. Callisto verfügt bereits über integrierte DNA-Extraktions-Workflows, die eine optimierte End-to-End-Lösung ermöglichen.Unser Ziel ist es, sicherzustellen, dass Kunden, die Sequenzierer der nächsten Generation
More news about: Volta Labs Inc.
Feb 26, 2026, 10:52 ET Advanced Materials for Vaginal Self-Collection Enabling High-Quality DNA Isolation, Upcoming Webinar Hosted by Xtalks
Discover how material innovation can improve DNA recovery from human samples and support the development of reliable non-invasive sampling devices. In this free webinar, attendees will learn how collection materials influence sample quality, transport stability, and biomolecule
More news about: Xtalks
Feb 26, 2026, 10:30 ET Inovio Pharmaceuticals, Inc. Stock Alert: INO Stockholders Who Lost Money in the Company Should Contact Robbins LLP for Information on How to Recover Their Losses
securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus ("HPV").
More news about: Robbins LLP
Feb 26, 2026, 09:15 ET Havas Health and BrightInsight Forge Exclusive Alliance to Tackle Pharma's $500B+ Patient Problem
platform with Havas' deep strategic influence and global reach, we can ensure that digital health solutions are successfully integrated into the brand's DNA and the patient's daily life, driving measurable impact for our partners and better outcomes for patients worldwide."This partnership represents
More news about: Havas Health Network
Feb 26, 2026, 09:00 ET Volta Labs Ignites AGBT 2026 with Major Product Launches and Industry-Shaping Partnerships
1–compatible automation solutions. Volta will look to integrate the AXELIOS 1 SBX-D prep workflow into the Callisto platform. Callisto already has onboard DNA extraction workflows, enabling a streamlined, end-to-end solution.Our goal is to ensure customers adopting next-generation sequencers can rely
More news about: Volta Labs Inc.
Feb 26, 2026, 09:00 ET Volta Labs Ignites AGBT 2026 with Major Product Launches and Industry-Shaping Partnerships
1–compatible automation solutions. Volta will look to integrate the AXELIOS 1 SBX-D prep workflow into the Callisto platform. Callisto already has onboard DNA extraction workflows, enabling a streamlined, end-to-end solution.Our goal is to ensure customers adopting next-generation sequencers can rely
More news about: Volta Labs Inc.
Feb 26, 2026, 08:34 ET LC Sign Launches Official Mascot T.Tony, Humanizing Its Global LC-MaaS™ Strategy
proprietary LC-MaaS™ framework.Defining T.Tony: The Soul of CraftsmanshipT.Tony is more than a mascot; he embodies LC Sign's core DNA: reliability, precision, and a customer-first service culture. Inspired by the leadership of LC Sign CMO Tony Zhu and the symbolic strength of the tiger
More news about: LC SIGN Co., Ltd.
Feb 26, 2026, 08:00 ET Orsini Now Distributing Gene Therapies LYFGENIA™, ZYNTEGLO™, SKYSONA™
TestingPatients who have received LYFGENIA are likely to test positive by polymerase chain reaction (PCR) assays for HIV due to integrated BB305 LVV proviral DNA, resulting in a possible false-positive PCR assay test result for HIV. Therefore, patients who have received LYFGENIA should not be screened for HIV
More news about: Orsini
Feb 26, 2026, 06:00 ET The Cynosure Group Acquires Utah Development and Construction Creating a New Joint Partnership with Clyde Capital Group
of Clyde Capital Group, underscored the strong strategic alignment between the two firms. "What makes this partnership truly special is our shared DNA," he added. "We're aligned in strategy, values, and purpose — from our dedication to building community to a mutual commitment to philanthropy and high-impact
More news about: Clyde Capital Group
Feb 25, 2026, 22:28 ET UEC Research and Innovation newsletter highlights breakthroughs in neuroscience, robotics, augmented reality, quantum physics, and global collaboration
Research Highlights Hidden cellular signals shape memory: Researchers discovered that mitochondrial DNA released during cellular stress activates pathways that weaken neural connections, offering new insights into memory formation.
More news about: University of Electro-Communications
Feb 25, 2026, 11:42 ET Illinois State Senator Julie Morrison Earns National AMA Honor for Transformative Public Health Leadership
embodies the spirit of inquiry and excellence modeled by its namesake, Dr. Rosalind Franklin, whose Photo 51 was crucial to solving the structure of DNA. Recognized for its research in areas including neuroscience, brain-related diseases, inherited disorders, diabetes, obesity, and gait and balance, RFU
More news about: Rosalind Franklin University of Medicine and Science
Feb 25, 2026, 11:00 ET Dental Burs Market to Reach US$ 1,232.3 Million by 2033 on Growth of Dental Procedures and Technological Innovation
Microarrays Market by product (Consumables, Software and Services, Instruments), Type (DNA Microarrays, Protein Microarrays, Other Microarrays), Application (Research Application, Drug Discovery, Disease Diagnostics, Other Applications), End
More news about: Persistence Market Research Pvt. Ltd.
Feb 25, 2026, 09:15 ET Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics
Spatial Technology to adnexal masses. The method enabled them to more easily differentiate between cancerous and benign tumor types using cell-free DNA and explore more sensitive ways to gain deeper biological context for ovarian cancer. Results included the first reported spatial analyses of adnexal
More news about: Illumina, Inc.
Feb 25, 2026, 09:00 ET GoPro and ASUS Co-Branded ProArt Laptop Available Globally
close collaboration between GoPro and ASUS to streamline the storytelling journey from capture to edit–combining GoPro's creator-first, go-anywhere DNA with ASUS' powerful, professional-ready hardware.
More news about: GoPro, Inc.
Feb 25, 2026, 08:12 ET Apricorn is the First and Only Hardware Encrypted USB External Storage Device Manufacturer to Achieve AS9100 Certification
quality controls. AS9100, as well as the other certifications we hold, reinforces that commitment which has always been a major part of Apricorn's DNA."With AS9100 certification in place, Apricorn is well positioned to expand its support for aerospace, aviation, and defense organizations seeking
More news about: Apricorn
Feb 25, 2026, 06:52 ET ACE Money Transfer and bKash Announce Ramadan Incentives for UK Bangladeshi Sending Money Home
Bank Group, Gates Foundation, Ant International, and SoftBank, operates under the regulation of Bangladesh Bank.Financial inclusion is in the DNA of bKash augmented by technological innovation drive & keeping compliance in all its dealings. Over the years, bKash has built a robust network of
More news about: ACE Money Transfer
Feb 25, 2026, 06:30 ET CGI positioned as Best in Class in the PAC RADAR Leaders in Sovereign AI-related Services in Europe 2026
market positioning, and performance within specific market segments.About PACWe are a content-based company with a consulting DNA. PAC is the leading European consulting and analyst firm supporting software & IT service vendors worldwide. Since 1976, we have helped our clients
More news about: CGI Inc.
Feb 25, 2026, 06:00 ET IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE034, a Potential First-In-Class B7H3/PTK7 Bispecific TOP1 ADC
evaluate safety, tolerability and PK of IDE034 as a monotherapy in the Phase 1 trial, and also plans to test combinations with agents that target the DNA damage response (DDR) pathway, such as their proprietary PARG inhibitor, IDE161. Dosing of the first patient with IDE034 triggers a $5 million milestone
More news about: IDEAYA Biosciences, Inc.
Feb 24, 2026, 16:03 ET Revolve Group Announces Fourth Quarter and Full Year 2025 Financial Results
even more excited about what lies ahead," said co-founder and co-CEO Michael Mente. "We are confident that our culture of innovation and technology DNA will allow us to remain a leader in the continued wave of AI innovation, driving higher conversion and efficiency. We are in a unique and opportunistic
More news about: Revolve Group, Inc.
Feb 24, 2026, 13:30 ET Direct Genome-Scale Mapping of Endonuclease Activity of the Human LINE-1 ORF2p Endonuclease
by identifying DNA nicking events on long DNA molecules. This capability addresses challenges associated with mapping endonuclease-induced nicks within complex DNA mixtures. Beyond endonuclease activity, future applications of EGM may enable direct, genome-wide analysis of additional DNA modifications
More news about: Nabsys